(Q40373029)

19 September 2017

Interaction between the androgen receptor and RNase L mediates a cross-talk between the interferon and androgen signaling pathways (English)

1 reference

19 September 2017

David J Bettoun

1

1 reference

19 September 2017

Angela Scafonas

2

1 reference

19 September 2017

Su Jane Rutledge

3

1 reference

19 September 2017

Paul Hodor

4

1 reference

19 September 2017

Oliver Chen

5

1 reference

19 September 2017

Carlo Gambone

6

1 reference

19 September 2017

Robert Vogel

7

1 reference

19 September 2017

Sheila McElwee-Witmer

8

1 reference

19 September 2017

Chang Bai

9

1 reference

19 September 2017

Leonard Freedman

10

1 reference

19 September 2017

Azriel Schmidt

11

1 reference

19 September 2017

language of work or name

English

0 references

publication date

14 September 2005

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

280

1 reference

19 September 2017

38898-38901

1 reference

19 September 2017

47

1 reference

Stromal fibroblasts in cancer initiation and progression

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Implications for RNase L in prostate cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Prospects for the treatment of endocrine-responsive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Androgens induce divergent proliferative responses in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

The role of androgens and the androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Profiling of hepatic gene expression in rats treated with fibric acid analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Activation of RNase L by 2',5'-oligoadenylates. Kinetic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

2-5A-dependent RNase molecules dimerize during activation by 2-5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

RNASEL mutations in hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Corepressor recruitment by agonist-bound nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C500324200

21 January 2018

Identifiers

DOI

10.1074/JBC.C500324200

1 reference

19 September 2017

1 reference